Abstract:Introduction: Adolescents with mental disorders show an increased risk of suicidal phenomena. Vice versa, suicidality is a serious adverse event of psychotropic drug therapy in adolescents. There are only a few new psychotropic agents approved for this young age group. We evaluated the (pre-pandemic) prevalence of off-label use as well as detailed blood concentrations of outpatient psychotropic medication and sex differences in a clinical population of suicidal adolescents. Methods: The urine presence and serum levels of psychotropic substances of adolescents hospitalized due to their acute suicidality but without a known actual suicide attempt (i.e., no acute intoxication or serious self-injuries) were investigated routinely between 01.03.2017 and 31.01.2018. Urine ( N = 205) and blood samples ( N = 193) were taken at the beginning of closed inpatient admission, i.e., the results of the laboratory analysis reflect outpatient drug intake. The serum levels of psychopharmacological medication and OTC medication were measured. Results: Our sample consists of 231 cases (boys: N = 54; girls: N = 177, ratio: 1:3.3), aged 12–17 years (average age: 15,4 years). The most prevalent psychiatric diagnoses were depressive episodes (54%) and adjustment disorders (25%), and girls were more often diagnosed with depressive disorders than boys (boy/girl ratio: 1:9.5, p < 0.0001). More than half of adolescents (56%) used at least one prescribed psychotropic drug at admission (24.8% ≥ two psychotropic drugs). Off-label use of second-generation antipsychotics was significantly more frequent than off-label use of antidepressants (85% vs. 31%, p < 0.01). Adolescents suffering from depressive disorders were significantly more often on-label treated than adolescents with neurotic or stress-related disorders (56% vs. 10%). Female cases with prescribed psychotropic drug use showed significantly more frequent supratherapeutic drug levels than male cases (5% vs. 27%, p < 0.05). Conclusion: Female adolescents may have an increased risk of supratherapeutic blood levels, especially when outpatient prescribed psychotropic drugs are off-label used. Measurement of blood levels of outpatient-prescribed psychotropic drugs could be used to enhance the safety and efficacy of the individual psychopharmacological treatment of adolescent suicidal patients. There is an urgent need for more real-world evidence on the effective treatment of adolescents with psychotropic drugs.

Medication Treatment for Youth in Substance Use Disorder Residential Treatment

Substance Use among Youth in Community and Residential Mental Health Care Facilities in Ontario, Canada

Substance use and psychiatric disorders in Irish adolescents: a cross-sectional study of patients attending substance abuse treatment service

Psychotropic medication use among adolescents participating in three randomized trials of DBT

Substance Use among Youth Presenting to the Pediatric Emergency Department

Substance use patterns and mental health comorbidities in youth with a history of depression or suicidality: Findings from TX-YDSRN

Transitional challenges: Psychotropic medication and residential setting among young adults with intellectual disabilities

Characterizing psychopharmacological prescribing practices in a large cohort of adolescents with borderline personality disorder

Psychotropic Medication Administration in Pediatric Emergency Departments

Psychiatric comorbidity in hospitalized adolescent substance abusers

DSM-5 Substance Use Disorders among Adult Primary Care Patients: Results from a Multisite Study.

Adolescent Residential Addiction Treatment In The US: Uneven Access, Waitlists, And High Costs

A case of severe opioid and methamphetamine use disorder in a 14 year old

Adolescent Substance Use Disorder in Primary Care: Challenges in Treatment Referral Beyond Access Availability

Do Substances Used in Adolescence Predict the Persistence of Substance Use Disorders in Adulthood? A 15-Year Study of Youth After Detention

The prevalence of off-label use and supratherapeutic blood levels of outpatient psychotropic medication in suicidal adolescents

Factors Associated with Substance Use Disorder among High-Need Adolescents and Young Adults in North Carolina

The substance use disorder treatment gap among US college students: Findings from the 2021 National Survey on Drug Use and Health

Longitudinal Patterns of Community-Based Treatment Utilization Among Ethnically and Racially Diverse Adolescents with Attention-Deficit/Hyperactivity Disorder

Prescribed sedative and other psychotropic medication use among clients attending alcohol and other drug treatment

Treatment Readiness in Psychiatric Residential Care for Adolescents